Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 514

1.

Design Principles of Ionic Liquids for Transdermal Drug Delivery.

Tanner EEL, Curreri AM, Balkaran JPR, Selig-Wober NC, Yang AB, Kendig C, Fluhr MP, Kim N, Mitragotri S.

Adv Mater. 2019 Jul;31(27):e1901103. doi: 10.1002/adma.201901103. Epub 2019 May 21.

PMID:
31112631
2.

Effects of acarbose and siglitine on blood glucose fluctuation and islet β-cell function in patients with type 2 diabetes mellitus.

Wang RR, Lv ZM, Dan YP, Chen KY, Zhang C.

J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2):365-374.

PMID:
30972995
3.

Effect of acarbose on cardiovascular events and new-onset diabetes in patients with coronary heart disease and impaired glucose tolerance.

Wei Y, Xu W.

Future Cardiol. 2019 Mar;15(2):127-133. doi: 10.2217/fca-2018-0062. Epub 2019 Feb 22. Review.

PMID:
30793928
4.

The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome.

Baxter NT, Lesniak NA, Sinani H, Schloss PD, Koropatkin NM.

mSphere. 2019 Feb 6;4(1). pii: e00528-18. doi: 10.1128/mSphere.00528-18. Erratum in: mSphere. 2019 May 22;4(3):.

5.

Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Moelands SV, Lucassen PL, Akkermans RP, De Grauw WJ, Van de Laar FA.

Cochrane Database Syst Rev. 2018 Dec 28;12:CD005061. doi: 10.1002/14651858.CD005061.pub3.

PMID:
30592787
6.

Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria.

Pan Q, Xu Y, Yang N, Gao X, Liu J, Yang W, Wang G.

Med Sci Monit. 2018 Dec 10;24:8941-8949. doi: 10.12659/MSM.911979.

7.

Cardiovascular Benefits of Acarbose vs Sulfonylureas in Patients With Type 2 Diabetes Treated With Metformin.

Hsu PF, Sung SH, Cheng HM, Shin SJ, Lin KD, Chong K, Yen FS, Yu BH, Huang CT, Hsu CC.

J Clin Endocrinol Metab. 2018 Oct 1;103(10):3611-3619. doi: 10.1210/jc.2018-00040.

PMID:
30113697
8.

Saxagliptin Upregulates Nesfatin-1 Secretion and Ameliorates Insulin Resistance and Metabolic Profiles in Type 2 Diabetes Mellitus.

Chen K, Zhuo T, Wang J, Mei Q.

Metab Syndr Relat Disord. 2018 Sep;16(7):336-341. doi: 10.1089/met.2018.0010. Epub 2018 Jun 18.

PMID:
29912623
9.

What does the Acarbose Cardiovascular Evaluation (ACE) trial tell us?

Holman RR.

J Diabetes. 2018 Aug;10(8):683-685. doi: 10.1111/1753-0407.12770. Epub 2018 May 17. No abstract available.

PMID:
29774661
10.

Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.

Theodorakis MJ, Coleman RL, Feng H, Chan J, Chiasson JL, Ge J, Gerstein HC, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Tendera M, Tuomilehto J, Yang W, Hu D, Pan C, Holman RR; ACE Study Group.

Am Heart J. 2018 May;199:170-175. doi: 10.1016/j.ahj.2017.09.001. Epub 2017 Sep 8. No abstract available.

PMID:
29754657
11.

Pharmacoeconomic evaluation of glimepiride combined with other drugs in the treatment of diabetes.

Liu X, Zeng L, Xu W.

Pak J Pharm Sci. 2018 May;31(3(Special)):1103-1107.

PMID:
29735458
12.

Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Davis TME, Mulder H, Lokhnygina Y, Aschner P, Chuang LM, Raffo Grado CA, Standl E, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Obes Metab. 2018 Jun;20(6):1427-1434. doi: 10.1111/dom.13242. Epub 2018 Feb 28.

PMID:
29405540
13.

Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment.

Gu Y, Wang X, Li J, Zhang Y, Zhong H, Liu R, Zhang D, Feng Q, Xie X, Hong J, Ren H, Liu W, Ma J, Su Q, Zhang H, Yang J, Wang X, Zhao X, Gu W, Bi Y, Peng Y, Xu X, Xia H, Li F, Xu X, Yang H, Xu G, Madsen L, Kristiansen K, Ning G, Wang W.

Nat Commun. 2017 Nov 27;8(1):1785. doi: 10.1038/s41467-017-01682-2.

14.

Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report.

Cohn A, Ohri A.

J Med Case Rep. 2017 Nov 12;11(1):319. doi: 10.1186/s13256-017-1462-5.

15.

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.

Holman RR, Coleman RL, Chan JCN, Chiasson JL, Feng H, Ge J, Gerstein HC, Gray R, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Sun Y, Theodorakis MJ, Tendera M, Tucker L, Tuomilehto J, Wei Y, Yang W, Wang D, Hu D, Pan C; ACE Study Group.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):877-886. doi: 10.1016/S2213-8587(17)30309-1. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7. Lancet Diabetes Endocrinol. 2019 May;7(5):e5.

PMID:
28917545
16.

Dietary Flavonoids and Acarbose Synergistically Inhibit α-Glucosidase and Lower Postprandial Blood Glucose.

Zhang BW, Li X, Sun WL, Xing Y, Xiu ZL, Zhuang CL, Dong YS.

J Agric Food Chem. 2017 Sep 27;65(38):8319-8330. doi: 10.1021/acs.jafc.7b02531. Epub 2017 Sep 15.

PMID:
28875706
17.

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus.

Wu H, Liu J, Lou Q, Liu J, Shen L, Zhang M, Lv X, Gu M, Guo X.

Medicine (Baltimore). 2017 Sep;96(35):e7533. doi: 10.1097/MD.0000000000007533.

18.

Pneumatosis Cystoides Coli Related to Acarbose Treatment.

Liao YH, Lo YP, Liao YK, Lin CH.

Am J Gastroenterol. 2017 Jul;112(7):984. doi: 10.1038/ajg.2017.88. No abstract available.

PMID:
28725063
19.

α-Glucosidase inhibitory effect of resveratrol and piceatannol.

Zhang AJ, Rimando AM, Mizuno CS, Mathews ST.

J Nutr Biochem. 2017 Sep;47:86-93. doi: 10.1016/j.jnutbio.2017.05.008. Epub 2017 May 25.

PMID:
28570943
20.

Rumen microbial and fermentation characteristics are affected differently by acarbose addition during two nutritional types of simulated severe subacute ruminal acidosis in vitro.

Wang Y, Liu J, Yin Y, Zhu W, Mao S.

Anaerobe. 2017 Oct;47:39-46. doi: 10.1016/j.anaerobe.2017.04.003. Epub 2017 Apr 7.

PMID:
28392309

Supplemental Content

Loading ...
Support Center